ASCO GUIDELINES Bundle

Invasive Cervical Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/792921

Contents of this Issue

Navigation

Page 15 of 17

16 Treatment Table 4. Recommendations for Stage IIB, III, IVA, and IVB and Recurrent Disease (cont'd) Type of Disease Basic Limited Recurrent Palliative care (EB, H, S) and/or central disease: chemotherapy (CB, In, W) Depending on previous RT and either "no prior RT or failure outside of previously treated field" then may offer tumor- directed RT plus platinum-based chemotherapy (EB, H, S) Note is is best managed with exenteration (type of surgery that is not feasible to perform in low-resource setting ) Prior RT plus noncentral disease: chemotherapy or best palliative care (EB, H, S) NOTE. Bold indicates addition of a recommended action over a previous resource level (eg, in limited setting, a bold action is one that was not recommended in basic). Additional recommendations regarding settings with limited radiotherapy resources are provided in the main article. a Recommended in setting where chemotherapy is not consistently available. b When brachytherapy is not available, extrafascial or radical hysterectomy is recommended only when there is persistent central pelvic disease and selective lymphadenectomy or LN biopsy for suspicious lesions. c Margins for dysplasia or carcinoma.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Invasive Cervical Cancer